Amino acids are fundamental building blocks, which have been extensively used in drug design and organic synthesis. However, nonnatural amino acids are relatively less studied. In this work, the authors report the first HFIP-promoted de novo synthesis of nonnatural a-arylated amino esters and dipeptide mimetics (27 examples, up to 99 %y ield) from readily available amines, ethyl glyoxylate and electron-rich arenes under mild conditions, in which one CÀCb ond, one CÀNb ond ando ne chiral center were established simultaneously. Ther eaction was also performedo nagram scale, giving compound 4a in 96 %y ield. In addition,t his protocol was successfully applied to the late-stage elaboration of drugm olecules, such as tranylcypromine (TCP or PCPA) andt roxipide.I nterestingly,c ompound 4h inactivated histone lysine specific demethylase 1( LSD1) potently with an IC 50 value of 0.296 mm.T ot he best of our knowledge,c ompound 4h is the first LSD1 inhibitor derived from nonnatural a-arylated amino esters, and therefore could be used as ah it compound for the development of new LSD1 inhibitors. The synthesized nonnatural a-arylated amino esters and dipeptidem imeticsa su nique building blocks may have potential synthetic utilities.